2026-06-14T03:31:27Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/93342024-11-29T17:01:33Zcom_20.500.12105_2173com_20.500.12105_2051col_20.500.12105_19597

00925njm 22002777a 4500 dc Barrio, Santiago author Munawar, Umair author Zhu, Yuan Xiao author Giesen, Nicola author Shi, Chang-Xin author Da Viá, Matteo author Sanchez, Richard author Bruins, Laura author Demler, Theresa author Müller, Nicole author Haertle, Larissa author Garitano, Andoni author Steinbrunn, Torsten author Danhof, Sophia author Cuenca, Isabel author Barrio-Garcia, Clara author Braggio, Esteban author Rosenwald, Andreas author Martinez-Lopez, Joaquin author Rasche, Leo author Raab, Marc S author Stewart, A Keith author Einsele, Hermann author Stühmer, Thorsten author Kortüm, K Martin author 2019-09-26 Haematologica. 2019 pii: haematol.2019.217943. 10.3324/haematol.2019.217943 1592-8721 0390-6078 Haematologica 31558666 http://hdl.handle.net/20.500.12105/9334 CRL4/CRBN E3 ubiquitin ligase Immunomodulatory drugs Multiple Myeloma Point mutations Drug resistance IKZF1/3 and CRL4-CRBN E3 ubiquitin ligase mutations and IMiD resistance in multiple myeloma